These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10667236)

  • 1. Inhibition of protein tyrosine kinase activity by 1a-docosahexaenoyl mitomycin C.
    Shikano M; Onimura K; Fukazawa H; Mizuno S; Yazawa K; Uehara Y
    Ann N Y Acad Sci; 1999; 886():269-72. PubMed ID: 10667236
    [No Abstract]   [Full Text] [Related]  

  • 2. 1a-docosahexaenoyl mitomycin C: a novel inhibitor of protein tyrosine kinase.
    Shikano M; Onimura K; Fukai Y; Hori M; Fukazawa H; Mizuno S; Yazawa K; Uehara Y
    Biochem Biophys Res Commun; 1998 Jul; 248(3):858-63. PubMed ID: 9704018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell division in Erwinia: inhibition of nuclear body division in filaments grown in penicillin or mitomycin C.
    Grula EA; Smith GL; Grula MM
    Science; 1968 Jul; 161(3837):164. PubMed ID: 5657062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of mitomycin C on energy metabolism: essential role of aerobic glycolysis in proliferation of L cells.
    Ohsaka N; Yonezu T; Hosokawa K; Yamaguchi H
    Cell Mol Biol; 1986; 32(4):477-85. PubMed ID: 3091248
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of human fibroblast interferon on the antiviral activity of mammalian cells treated with bleomycin, vincristine, or mitomycin C.
    Suhadolnik RJ; Sawada Y; Flick MB; Reichenbach NL; Mosca JD
    Cancer Res; 1983 Nov; 43(11):5462-6. PubMed ID: 6193871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different lethal effects of mitomycin C and actinomycin D during the division cycle of HeLa cells.
    Djordjevic B; Kim JH
    J Cell Biol; 1968 Sep; 38(3):477-82. PubMed ID: 5664219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of differentiated type 2 cell function in the A549 cell line using mitomycin C1.
    Palmer KC; Mooradian DL; Diglio CA
    Pathol Immunopathol Res; 1987; 6(3):221-33. PubMed ID: 2827138
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of protein tyrosine kinase inhibitors with different modes of action on topoisomerase activity and death of IL-2-dependent CTLL-2 cells.
    Azuma Y; Onishi Y; Sato Y; Kizaki H
    J Biochem; 1995 Aug; 118(2):312-8. PubMed ID: 8543564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative clonal growth of mammalian cells: its application for quantitative study of cytocidal action of Mitomycin-C.
    Shimoyama M; Kimura K
    Gan; 1972 Dec; 63(6):773-83. PubMed ID: 4675119
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction of phage-like particles from a pathogenic strain of Vibrio parahaemolyticus by mitomycin C.
    Ohnishi T; Nozu K
    Biochem Biophys Res Commun; 1986 Dec; 141(3):1249-53. PubMed ID: 3101681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precocious desynapsis of XY-bivalent in mouse germinal cells: influence of mitomycin C on tumour-bearing and normal mice.
    Dey D; Pradhan M; Das SB; Chakrabarti S
    Indian J Exp Biol; 1989 Sep; 27(9):757-60. PubMed ID: 2517268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the ras signaling pathway.
    Clark JW; Santos-Moore A; Stevenson LE; Frackelton AR
    Int J Cancer; 1996 Jan; 65(2):186-91. PubMed ID: 8567115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The pharmacological inhibition of the intracellular signals involved in cellular proliferation: a cardiovascular approach].
    Villanueva LA; Guarner V
    Arch Inst Cardiol Mex; 1999; 69(3):265-71. PubMed ID: 10529861
    [No Abstract]   [Full Text] [Related]  

  • 14. Growth inhibition and cell enlargement in P-388 cells treated with mitomycin C.
    Orstavik J
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1972; 80(4):519-24. PubMed ID: 4509187
    [No Abstract]   [Full Text] [Related]  

  • 15. Kinetic evaluation of the effect of actinomycin D, daunomycin, and mitomycin C on proliferating cultured leukemia L 1210 cells.
    Wilkoff LJ; Lloyd HH; Dulmadge EA
    Chemotherapy; 1971; 16(1):44-60. PubMed ID: 5102829
    [No Abstract]   [Full Text] [Related]  

  • 16. Caffeine sensitive recovery of mitomycin C treated mouse P-388 cells.
    Orstavik J
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1972; 80(6):900-4. PubMed ID: 4509396
    [No Abstract]   [Full Text] [Related]  

  • 17. Interleukin 10 modulation of tumour necrosis factor receptors requires tyrosine kinases but not the PI 3-kinase/p70 S6 kinase pathway.
    Williams L; Lali F; Clarke C; Brennan F; Foxwell B
    Cytokine; 2000 Jul; 12(7):934-43. PubMed ID: 10880238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of medullary thyroid carcinoma cell proliferation and RET phosphorylation by tyrosine kinase inhibitors.
    Cohen MS; Hussain HB; Moley JF
    Surgery; 2002 Dec; 132(6):960-6; discussion 966-7. PubMed ID: 12490842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interferon-induced hyporesponsive state in variant and parental L cells: a requirement for cell division.
    Veomett GE; Lahm BD; Hawkins J
    J Gen Virol; 1983 Aug; 64 (Pt 8)():1735-41. PubMed ID: 6409991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of caffeine on mitomycin C induced mutagenesis.
    Kim J; Levin RE
    Microbios; 1986; 46(186):15-20. PubMed ID: 3090403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.